What are the red flags for Richard J. Pollack?

AHA Dossiers Power Map About

Richard J. Pollack

Former AHA leadership · Former President & CEO (2015-2026)

President & CEO Emeritus (former President & CEO) | American Hospital Association

Last verified November 4, 2026

7 Red Flags

Affiliations

•Served as AHA President & CEO from 2015 until his retirement in September 2026, when Steve Walsh, former CEO of the Massachusetts Health & Hospital Association, took over.
•Spent 43 years at the AHA after joining in 1982, including more than 20 years as Executive Vice President for Advocacy and Public Policy, which made him the association's chief Washington lobbyist before he became CEO.
•The AHA board voted in December 2025 to give him the title AHA President & CEO Emeritus, effective when the transition was complete; AHA was using that title for him by September 30, 2026.
•Started his career as a legislative assistant to Rep. David Obey (D-Wis.), then worked as a legislative representative at the American Nurses Association starting in 1980 before moving to the AHA.
•Received The Joint Commission's inaugural Lifetime Service Award, announced September 30, 2026. The Joint Commission is the accreditor whose seal hospitals rely on for Medicare deemed status.
•Holds a bachelor's degree from SUNY Cortland and an MPA from American University.

Financial / Compensation

•FY2024 Form 990: Pollack received $5,823,759 in reportable compensation plus $55,174 in other compensation, about $5.88 million in total. That is up roughly 71% from $3,396,123 in 2023.
•Paddock Post's analysis of AHA 990s puts his pay at $2.50M (2017), $2.75M (2018), $4.70M (2019), $3.15M (2020), $3.14M (2021), $3.18M (2022) and $3.40M (2023), or about $23 million over 2017-2023. Adding FY2024 brings the eight-year total to about $29 million.
•AHA FY2024 (calendar 2024) Form 990: revenue of $146.7 million against expenses of $169.3 million, a deficit of about $22.6 million. Net assets fell from $289.8 million to $277.6 million.
•In 2023, AHA paid $78 million in compensation to 431 employees, an average of about $181,000. Its 16 highest-paid employees received about $17 million combined.
•Other top FY2024 AHA pay: COO Michelle Hood got $1.92M, EVP Government Relations Stacey Hughes $1.70M plus $294K other, General Counsel Chad Golder $1.07M, SVP Chris DeRienzo $887K, and GVP Lisa Kidder Hrobsky $712K.
•In a June 2026 statement, AHA credited Pollack with growing the association's net assets 57% through 2024, non-dues revenue 26% and total revenue 15%. Operating expenses also rose.

Lobbying and Political

•AHA's Senate lobbying filings show $25.47 million in federal lobbying in 2025, Pollack's last full year as CEO, and roughly $194 million since 2018.
•AHA reported about $10.55 million in federal lobbying for January-June 2026, down 20% from the first half of 2025, during the CEO transition year.
•AHA spent $7 million on lobbying in Q1 2025 alone, working on Medicare financing, the healthcare workforce and the Medicaid provisions of the 2025 reconciliation bill.
•The AHA PAC reported $1.81 million in receipts and $3.74 million in spending for the 2024 cycle, including $1.83 million in independent expenditures.
•In his last months as CEO, Pollack led the fight against HHS's 340B rebate model. On July 31, 2026, he said AHA was 'considering all available options' to stop it, and AHA sued on October 9, 2026.
•Pollack has described AHA's influence operation in terms of grassroots networks in every congressional district, PAC money, coalitions and advertising, calling grassroots 'absolutely king.'

Revolving Door

•His career ran from congressional staff (Rep. David Obey) to nurse-association lobbyist to AHA lobbyist to AHA CEO, a Washington insider path spanning more than 45 years.
•As AHA's top lobbyist for more than two decades before becoming CEO, he was a registered federal lobbyist for the association.
•His successor, Steve Walsh, also comes from government: six terms in the Massachusetts House, where he chaired the health care financing committee, followed by state hospital association CEO since 2017. The AHA board picked another lobbyist-legislator, not an operator.
•As President & CEO Emeritus, Pollack keeps a formal title and public profile at the AHA after his retirement.

Home System Record

•AHA filed suit against HHS's hospital price transparency rule and lost in district court and again at the D.C. Circuit on December 29, 2020, clearing the rule to take effect January 1, 2021.
•On December 1, 2025, AHA, the Maine Hospital Association and four health systems sued in the U.S. District Court for the District of Maine to block HHS's 340B rebate pilot. Judge Lance Walker issued a preliminary injunction on December 29, 2025, the First Circuit denied a stay in January 2026, and HHS said on February 5, 2026 that it would scrap the pilot as designed.
•After HHS revised and expanded the 340B rebate model for a January 1, 2027 start, AHA filed a second suit in the District of Maine on October 9, 2026, and on October 21, 2026 opposed drug-industry intervention in the case.
•When the Senate HELP Committee majority staff found in October 2023 that 12 of 16 large nonprofit systems spent less than 2% of revenue on charity care, Pollack called the analysis 'just plain wrong.' He pointed to an AHA-commissioned EY study claiming about $9 in community benefit per $1 of tax exemption.
•AHA has long opposed lifting the federal restrictions on physician-owned hospitals, a position that protects incumbent systems from physician-led competition.

Litigation and Scrutiny

•American Hospital Association v. Azar (price transparency): AHA lost at the district court, and the D.C. Circuit affirmed on December 29, 2020.
•AHA et al. v. HHS (340B rebate pilot, D. Maine, filed December 1, 2025): the preliminary injunction granted December 29, 2025 was upheld when the First Circuit denied a stay in January 2026, and HHS withdrew the pilot as designed in February 2026.
•AHA et al. v. HHS (revised 340B rebate model, D. Maine, filed October 9, 2026): the suit seeks declaratory and injunctive relief to block the program before its January 1, 2027 start and was pending as of November 2026.
•On October 2, 2026, AHA filed an amicus brief backing a hospital's challenge to an Eli Lilly 340B policy.

Red Flags

His pay jumped to about $5.88 million in FY2024, up roughly 71% in one year, while the AHA ran a $22.6 million deficit and member hospitals were telling Congress they could not absorb Medicaid and site-neutral cuts.

Over 2017-2024 he collected about $29 million from a trade group funded mostly by dues from tax-exempt hospitals, so taxpayer-subsidized revenue ultimately paid for the lobbying chief.

Under him, AHA reported $25.47 million in federal lobbying in 2025, much of it spent to stop Medicaid financing reforms and site-neutral payment that would cut what Medicare pays for the same service depending on who owns the building.

He spent AHA money in court against price transparency (lost in 2020) and against 340B rebates (2025 and 2026), consistently opposing patients and payers seeing prices or auditing discounts.

He dismissed independent charity-care findings ('just plain wrong') and relied on an industry-commissioned EY study that counts Medicaid shortfalls and other self-reported items as community benefit.

He leaves with an emeritus title and a Joint Commission lifetime award, which keeps an industry lobbyist inside quality-oversight circles after retirement.

The board replaced him with another politician-lobbyist (Walsh), signaling that AHA treats its job as political defense of hospital revenue rather than reform.

Pattern Summary

Rick Pollack spent 43 years turning the AHA into one of Washington's most effective incumbent-protection machines, and left in September 2026 at the top of his earning power, with about $5.88 million in FY2024 pay and $25.47 million in federal lobbying in 2025. His tenure follows a consistent playbook: sue to block price transparency and 340B accountability, dismiss independent charity-care critiques, and fight any payment reform that pays equally for equal services. The board's choice of another career politician to replace him signals the strategy will not change.

Richard J. Pollack

Red Flags

Sources and Citations